Literature DB >> 34453689

Correlation Between Sex Hormones and Non-alcoholic Fatty Liver Disease Before and After Laparoscopic Sleeve Gastrectomy.

Diliqingna Dilimulati1, Meili Cai1, Ziwei Lin1,2, Yuqin Zhang1, Lei Du1,3, Donglei Zhou1,3, Jiangfan Zhu1,3, Lili Su1,3, Yu Wang1,3, Manna Zhang4,5, Shen Qu6,7.   

Abstract

OBJECTIVES: To investigate the cross-sectional and longitudinal correlation between sex hormones and non-alcoholic fatty liver disease (NAFLD) in patients with obesity before and after laparoscopic sleeve gastrectomy (LSG).
METHODS: A total of 360 patients with obesity aged 16-48 years (170 men and 190 women) were enrolled between May 2017 and March 2021. Among them, 132 patients (55 men and 77 women) who underwent LSG had follow-up data. Anthropometric parameters, metabolic variables, and sex hormones were measured. NAFLD was assessed by FibroScan with controlled attenuation parameter (CAP) and liver stiffness measurement (LSM).
RESULTS: In the preoperative cohort, levels of CAP and LSM were significantly higher in men than women. Lower total testosterone (TT) was associated with higher CAP and LSM in men, whereas higher TT was associated with higher CAP in women. In the postoperative cohort, TT levels and NAFLD were significantly modified after LSG in both genders. Changes in TT levels at 3 months after surgery were negatively correlated with changes in CAP levels in men, and changes in TT levels at 6 months after surgery were positively correlated with changes in CAP levels in women. After adjusting possible confounders, the changes in TT levels were independently correlated with CAP variation in both genders.
CONCLUSIONS: LSG significantly modified TT levels and NAFLD in both genders. The correlation between TT levels and NAFLD at baseline as well as the changes after surgery suggested TT levels play an important role in the development and regression of NAFLD in both genders.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  FibroScan; Laparoscopic sleeve gastrectomy; Non-alcoholic fatty liver disease; Obesity; Sex hormones

Mesh:

Substances:

Year:  2021        PMID: 34453689     DOI: 10.1007/s11695-021-05663-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   3.479


  42 in total

Review 1.  Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease.

Authors:  Mathis Grossmann; Margaret E Wierman; Peter Angus; David J Handelsman
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

Review 2.  Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps.

Authors:  Amedeo Lonardo; Fabio Nascimbeni; Stefano Ballestri; DeLisa Fairweather; Sanda Win; Tin A Than; Manal F Abdelmalek; Ayako Suzuki
Journal:  Hepatology       Date:  2019-09-23       Impact factor: 17.425

Review 3.  Non-alcoholic fatty liver disease - A global public health perspective.

Authors:  Zobair M Younossi
Journal:  J Hepatol       Date:  2018-11-09       Impact factor: 25.083

Review 4.  Estrogen and androgen receptors in liver: their role in liver disease and regeneration.

Authors:  P K Eagon; L E Porter; A Francavilla; A DiLeo; D H Van Thiel
Journal:  Semin Liver Dis       Date:  1985-02       Impact factor: 6.115

5.  Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife.

Authors:  Monika Sarkar; Melissa Wellons; Marcelle I Cedars; Lisa VanWagner; Erica P Gunderson; Veeral Ajmera; Laura Torchen; David Siscovick; J Jeffrey Carr; James G Terry; Mary Rinella; Cora E Lewis; Norah Terrault
Journal:  Am J Gastroenterol       Date:  2017-03-14       Impact factor: 10.864

6.  Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta-Analysis.

Authors:  Feng Zhou; Jianghua Zhou; Wenxin Wang; Xiao-Jing Zhang; Yan-Xiao Ji; Peng Zhang; Zhi-Gang She; Lihua Zhu; Jingjing Cai; Hongliang Li
Journal:  Hepatology       Date:  2019-10       Impact factor: 17.425

7.  Androgen receptor in human liver: characterization and quantitation in normal and diseased liver.

Authors:  P K Eagon; M S Elm; E A Stafford; L E Porter
Journal:  Hepatology       Date:  1994-01       Impact factor: 17.425

8.  Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor.

Authors:  Hung-Yun Lin; I-Chen Yu; Ruey-Shen Wang; Yei-Tsung Chen; Ning-Chun Liu; Saleh Altuwaijri; Cheng-Lung Hsu; Wen-Lung Ma; Jenny Jokinen; Janet D Sparks; Shuyuan Yeh; Chawnshang Chang
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

Review 9.  Nonalcoholic fatty liver disease: another leap forward.

Authors:  Manal F Abdelmalek
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02       Impact factor: 46.802

10.  The association of sex steroid hormone concentrations with non-alcoholic fatty liver disease and liver enzymes in US men.

Authors:  Hong Phan; Aline Richard; Mariana Lazo; William G Nelson; Samuel R Denmeade; John Groopman; Norma Kanarek; Elizabeth A Platz; Sabine Rohrmann
Journal:  Liver Int       Date:  2021-02       Impact factor: 5.828

View more
  2 in total

Review 1.  Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones.

Authors:  K Pafili; S A Paschou; E Armeni; S A Polyzos; D G Goulis; I Lambrinoudaki
Journal:  J Endocrinol Invest       Date:  2022-03-18       Impact factor: 5.467

2.  Serum Fibrinogen-Like Protein 1 Levels in Obese Patients Before and After Laparoscopic Sleeve Gastrectomy: A Six-Month Longitudinal Study.

Authors:  Diliqingna Dilimulati; Lei Du; Xiu Huang; Muthukumaran Jayachandran; Meili Cai; Yuqin Zhang; Donglei Zhou; Jiangfan Zhu; Lili Su; Manna Zhang; Shen Qu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-08-17       Impact factor: 3.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.